Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Yang Gao,
Jia‐Hui Xing,
Meng‐Meng Fu,
Jun Zhao,
Wei‐Ya Li,
Feng‐Kun Yang Helicobacter
· Wiley
· 2026-11-05
· DOI: 10.1111/hel.70167
The publisher did not provide an abstract — full text is available via the link below.
Yang Gao, Jia‐Hui Xing, Meng‐Meng Fu, Jun Zhao, Wei‐Ya Li, Feng‐Kun Yang. Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials. // Helicobacter. – 2026. – DOI: 10.1111/hel.70167. – URL: https://onlinelibrary.wiley.com/doi/10.1111/hel.70167?af=R
Yang Gao, Jia‐Hui Xing, Meng‐Meng Fu, Jun Zhao, Wei‐Ya Li, & Feng‐Kun Yang (2026). Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Helicobacter. https://doi.org/10.1111/hel.70167
Yang Gao, et al. “Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials.” Helicobacter, 2026. doi:10.1111/hel.70167.
@article{Gao2026,
title = {Efficacy and Safety of Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Regimens for First Line Helicobacter pylori Eradication—An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
author = {Gao, Yang and Xing, Jia‐Hui and Fu, Meng‐Meng and Zhao, Jun and Li, Wei‐Ya and Yang, Feng‐Kun},
journal = {Helicobacter},
year = {2026},
doi = {10.1111/hel.70167},
url = {https://onlinelibrary.wiley.com/doi/10.1111/hel.70167?af=R}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...